TipRanks
Yubo International Biotech (YBGJ)
OTHER OTC:YBGJ
US Market
YBGJ
Yubo International Biotech
RESEARCH TOOLSreports

Yubo International Biotech (YBGJ) Ratios

13 Followers

Yubo International Biotech Ratios

YBGJ's free cash flow for Q2 2026 was $0.00. For the 2026 fiscal year, YBGJ's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 22Dec 21
Liquidity Ratios
Current Ratio
 0.18 0.24 0.14 0.30 0.38
Quick Ratio
 0.17 0.23 0.14 0.17 0.32
Cash Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Solvency Ratio
 -0.25 -0.32 -0.33 -0.40 -0.32
Operating Cash Flow Ratio
 -0.11 -0.30 -0.28 0.03 -0.37
Short-Term Operating Cash Flow Coverage
 -23.67 0.00 -3.64 0.17 -1.33
Net Current Asset Value
$ -2.74M$ -2.12M$ -4.15M$ -2.16M$ -3.66M
Leverage Ratios
Debt-to-Assets Ratio
 0.02 0.09 0.31 0.34 0.59
Debt-to-Equity Ratio
 >-0.01 -0.04 -0.14 -1.40 -20.53
Debt-to-Capital Ratio
 >-0.01 -0.04 -0.16 3.51 1.05
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 -2.23 1.07
Financial Leverage Ratio
 -0.26 -0.43 -0.45 -4.15 -34.96
Debt Service Coverage Ratio
 -30.38 3.71K -4.33 -2.94 >-0.01
Interest Coverage Ratio
 -178.78 4.89K 0.00 -5.26K >-0.01
Debt to Market Cap
 0.02 0.00 0.09 0.07 0.05
Interest Debt Per Share
 <0.01 <0.01 <0.01 <0.01 3.64
Net Debt to EBITDA
 >-0.01 -0.07 -0.26 -0.66 -1.75
Profitability Margins
Gross Profit Margin
28.01%6.08%-6030.98%50.49%65.95%
EBIT Margin
-681.00%-883.76%-57113.60%-1155.72%-123.99%
EBITDA Margin
-593.18%-751.48%-51831.24%-1129.32%-122.27%
Operating Profit Margin
-743.23%-883.76%-51006.31%-1155.72%-123.99%
Pretax Profit Margin
-769.88%-883.94%-57112.16%-1155.50%-123.95%
Net Profit Margin
-694.87%-803.07%-51161.47%-1155.28%-123.92%
Continuous Operations Profit Margin
-673.54%-803.07%-57112.16%-1155.28%-123.92%
Net Income Per EBT
90.26%90.85%89.58%99.98%99.97%
EBT Per EBIT
103.59%100.02%111.97%99.98%99.97%
Return on Assets (ROA)
-138.91%-127.41%-115.67%-51.30%-33.62%
Return on Equity (ROE)
43.75%55.21%51.84%213.09%1175.33%
Return on Capital Employed (ROCE)
37.62%61.09%55.54%688.98%-85.85%
Return on Invested Capital (ROIC)
32.28%57.84%56.24%-535.25%-60.19%
Return on Tangible Assets
-147.67%-134.07%-119.60%-52.82%-33.90%
Earnings Yield
-105.38%-62.33%-42.76%-10.68%-3.13%
Efficiency Ratios
Receivables Turnover
 0.97 0.32 <0.01 0.30 2.22
Payables Turnover
 0.00 0.12 0.20 0.09 1.54
Inventory Turnover
 3.90 5.25 5.76 0.16 2.58
Fixed Asset Turnover
 4.06 1.10 <0.01 0.07 0.37
Asset Turnover
 0.20 0.16 <0.01 0.04 0.27
Working Capital Turnover Ratio
 -0.05 -0.04 0.00 -0.06 -2.26
Cash Conversion Cycle
 468.52 -1.84K 44.81K -400.64 68.05
Days of Sales Outstanding
 374.94 1.16K 46.53K 1.21K 164.13
Days of Inventory Outstanding
 93.58 69.50 63.40 2.28K 141.53
Days of Payables Outstanding
 0.00 3.07K 1.78K 3.89K 237.60
Operating Cycle
 468.52 1.23K 46.59K 3.49K 305.66
Cash Flow Ratios
Operating Cash Flow Per Share
 >-0.01 >-0.01 -0.01 <0.01 >-0.01
Free Cash Flow Per Share
 >-0.01 >-0.01 -0.01 <0.01 -0.01
CapEx Per Share
 <0.01 <0.01 0.00 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 0.42 1.55
Dividend Paid and CapEx Coverage Ratio
 -92.64K -421.40K 0.00 1.72 -1.81
Capital Expenditure Coverage Ratio
 -92.64K -421.40K 0.00 1.72 -1.81
Operating Cash Flow Coverage Ratio
 -23.67 -10.70 -2.79 0.09 -0.38
Operating Cash Flow to Sales Ratio
 -2.76 -6.27 -385.51 0.65 -0.82
Free Cash Flow Yield
-41.82%-48.67%-32.22%0.25%-3.22%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.80 -1.61 -2.34 -9.36 -31.94
Price-to-Sales (P/S) Ratio
 6.59 12.88 1.20K 108.15 39.58
Price-to-Book (P/B) Ratio
 -0.34 -0.89 -1.21 -19.95 -375.42
Price-to-Free Cash Flow (P/FCF) Ratio
 -2.39 -2.05 -3.10 396.28 -31.06
Price-to-Operating Cash Flow Ratio
 -2.39 -2.05 -3.10 165.29 -48.25
Price-to-Earnings Growth (PEG) Ratio
 -0.11 0.03 0.00 0.41 -0.27
Enterprise Value Multiple
 -1.12 -1.78 -2.57 -10.23 -34.13
Enterprise Value
 889.83K 1.80M 4.62M 12.05M 51.92M
EV to EBITDA
 -1.12 -1.78 -2.57 -10.23 -34.13
EV to Sales
 6.62 13.41 1.33K 115.56 41.72
EV to Free Cash Flow
 -2.40 -2.14 -3.46 423.41 -32.75
EV to Operating Cash Flow
 -2.40 -2.14 -3.46 176.61 -50.86
Tangible Book Value Per Share
 -0.02 -0.01 -0.03 >-0.01 >-0.01
Shareholders’ Equity Per Share
 -0.02 -0.01 -0.03 >-0.01 >-0.01
Tax and Other Ratios
Effective Tax Rate
 0.15 0.09 0.10 <0.01 <0.01
Revenue Per Share
 <0.01 <0.01 <0.01 <0.01 0.01
Net Income Per Share
 >-0.01 >-0.01 -0.01 -0.01 -0.01
Tax Burden
 0.90 0.91 0.90 1.00 1.00
Interest Burden
 1.13 1.00 1.00 1.00 1.00
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 -2.93 6.57 359.51 9.94 1.05
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.33 0.78 0.75 -0.06 0.66
Currency in USD